Mcgaughy R Kent Jr - Net Worth and Insider Trading
Mcgaughy R Kent Jr Net Worth
The estimated net worth of Mcgaughy R Kent Jr is at least $600 Million dollars as of 2024-09-18. Mcgaughy R Kent Jr is the Director, 10% Owner of Reata Pharmaceuticals Inc and owns about 3,096,181 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $534 Million. Mcgaughy R Kent Jr is the Director, 10% Owner of Apollo Endosurgery Inc and owns about 3,878,742 shares of Apollo Endosurgery Inc (APEN) stock worth over $39 Million. Mcgaughy R Kent Jr is also the Director of Instil Bio Inc and owns about 423,940 shares of Instil Bio Inc (TIL) stock worth over $27 Million. Details can be seen in Mcgaughy R Kent Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mcgaughy R Kent Jr has not made any transactions after 2021-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mcgaughy R Kent Jr
Mcgaughy R Kent Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mcgaughy R Kent Jr owns 5 companies in total, including Apollo Endosurgery Inc (APEN) , Reata Pharmaceuticals Inc (RETA) , and Genitope Corp (GTOPQ) among others .
Click here to see the complete history of Mcgaughy R Kent Jr’s form 4 insider trades.
Insider Ownership Summary of Mcgaughy R Kent Jr
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
APEN | Apollo Endosurgery Inc | 2021-10-15 | director & 10 percent owner |
RETA | Reata Pharmaceuticals Inc | 2019-11-18 | director & 10 percent owner |
GTOPQ | Genitope Corp | 2007-06-11 | director |
2022-03-17 | 10 percent owner | ||
2021-03-23 | director |
Mcgaughy R Kent Jr Latest Holdings Summary
Mcgaughy R Kent Jr currently owns a total of 3 stocks. Among these stocks, Mcgaughy R Kent Jr owns 3,096,181 shares of Reata Pharmaceuticals Inc (RETA) as of November 18, 2019, with a value of $534 Million and a weighting of 88.96%. Mcgaughy R Kent Jr owns 3,878,742 shares of Apollo Endosurgery Inc (APEN) as of October 15, 2021, with a value of $39 Million and a weighting of 6.47%. Mcgaughy R Kent Jr also owns 423,940 shares of Instil Bio Inc (TIL) as of March 23, 2021, with a value of $27 Million and a weighting of 4.58%.
Latest Holdings of Mcgaughy R Kent Jr
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RETA | Reata Pharmaceuticals Inc | 2019-11-18 | 3,096,181 | 172.36 | 533,657,757 |
APEN | Apollo Endosurgery Inc | 2021-10-15 | 3,878,742 | 10.00 | 38,787,420 |
TIL | Instil Bio Inc | 2021-03-23 | 423,940 | 64.79 | 27,467,073 |
Holding Weightings of Mcgaughy R Kent Jr
Mcgaughy R Kent Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Mcgaughy R Kent Jr has made a total of 1 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Reata Pharmaceuticals Inc is the acquisition of 40,218 shares on November 18, 2019, which cost Mcgaughy R Kent Jr around $7 Million.
According to the SEC Form 4 filings, Mcgaughy R Kent Jr has made a total of 2 transactions in Apollo Endosurgery Inc (APEN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Apollo Endosurgery Inc is the acquisition of 683,871 shares on October 15, 2021, which cost Mcgaughy R Kent Jr around $5 Million.
According to the SEC Form 4 filings, Mcgaughy R Kent Jr has made a total of 1 transactions in Instil Bio Inc (TIL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Instil Bio Inc is the acquisition of 22,500 shares on March 23, 2021, which cost Mcgaughy R Kent Jr around $9 Million.
Insider Trading History of Mcgaughy R Kent Jr
- 1
Mcgaughy R Kent Jr Trading Performance
GuruFocus tracks the stock performance after each of Mcgaughy R Kent Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mcgaughy R Kent Jr is 12.92%. GuruFocus also compares Mcgaughy R Kent Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mcgaughy R Kent Jr within 3 months outperforms 12 times out of 19 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mcgaughy R Kent Jr's insider trading performs compared to the benchmark.
Performance of Mcgaughy R Kent Jr
Mcgaughy R Kent Jr Ownership Network
Mcgaughy R Kent Jr Owned Company Details
What does Apollo Endosurgery Inc do?
Who are the key executives at Apollo Endosurgery Inc?
Mcgaughy R Kent Jr is the director & 10 percent owner of Apollo Endosurgery Inc. Other key executives at Apollo Endosurgery Inc include 10 percent owner Antal Rohit Desai , Chief Financial Officer Jeffrey G. Black , and VP & Int'l Sales and Marketing Mike Gutteridge .
Apollo Endosurgery Inc (APEN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Apollo Endosurgery Inc (APEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apollo Endosurgery Inc (APEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Apollo Endosurgery Inc (APEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apollo Endosurgery Inc Insider Transactions
Mcgaughy R Kent Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Mcgaughy R Kent Jr. You might contact Mcgaughy R Kent Jr via mailing address: 500 Crescent Court, Suite 250, Dallas Tx 75201.